ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,69
0,14%
Dow Jones
43 297,03
0,91%
DAX
19 848,77
-0,34%
Brent Oil
73,555
0,37%
Bitcoin
95 524,85
-3,80%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. C4 Therapeutics Inc (CCCC) Cours

C4 Therapeutics Inc

C4 Therapeutics Inc (CCCC)

NASDAQ
3,87
-0,19
(-4,68%)
Fermé 24 Décembre 10:00PM
Retardé de 15 minutes
3,87
0,00
( 0,00% )
Avant marché: 10:26AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
3,87
Prix Achat
3,70
Prix Vente
3,89
Volume échangé
1 292
0,00 Fourchette du Jour 0,00
3,61 Plage de 52 semaines 11,88
Cap du marché
273,179M
Clôture Veille
3,87
Ouverture
-
Dernière Transaction
5
@
3.86
Dernière heure de transaction
10:58:48
Volume financier
-
VWAP
-
Volume moyen (3 m)
1 248 325
Actions en circulation
70 588 959
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,06
Bénéfice par action (BPA)
-1,88
Chiffre d'affairess
20,76M
Bénéfice net
-132,49M

À propos de C4 Therapeutics Inc

C4 Therapeutics Inc is a bio-pharmaceutical company. The company is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to eliminate disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases. C4 Therapeutics Inc is a bio-pharmaceutical company. The company is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to eliminate disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.c4therapeutics.com
Siège social
Wilmington, Delaware, USA
Fondé
-
C4 Therapeutics Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker CCCC. Le dernier cours de clôture d'C4 Therapeutics était de US$3,87. Au cours de la dernière année, les actions de C4 Therapeutics ont été négociées dans une fourchette de prix de US$ 3,61 à US$ 11,88.

C4 Therapeutics compte actuellement 70 588 959 actions en circulation. La capitalisation boursière d'C4 Therapeutics est de US$273,18 million. C4 Therapeutics a un ratio cours/bénéfice (ratio PE) de -2.06.

CCCC Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

09 Décembre 2024
Edgar (US Regulatory)

C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader

In Multiple Myeloma, Cemsidomide in Combination with Dexamethasone at Highest Dose Level Explored to Date Achieved 36 Percent Overall Response Rate (ORR) and 45 Percent Clinical Benefit Rate...

08 Décembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

20 Novembre 2024
Edgar (US Regulatory)

C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors

Hoerter Brings Over Three Decades of Oncology Commercialization and Leadership Experience Appointment Underscores Continued Transformation of Board to Lead C4T into Next Phase of Pipeline Progress...

20 Novembre 2024
GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities

18 Novembre 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

15 Novembre 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

15 Novembre 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Novembre 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.08-2.02531645573.954.213.69526296593.93557095CS
4-0.7102-15.5058731064.58025.13.6119818634.14290441CS
12-1.53-28.33333333335.47.143.6112483254.74592444CS
26-0.78-16.77419354844.657.663.6113253385.38659966CS
52-0.62-13.80846325174.4911.883.6122122566.47382586CS
156-29.57-88.427033492833.4434.641.0621150135.84960484CS
260-22.73-85.451127819526.651.211.0616092667.98082798CS

CCCC - Frequently Asked Questions (FAQ)

What is the current C4 Therapeutics share price?
The current share price of C4 Therapeutics is US$ 3,87
How many C4 Therapeutics shares are in issue?
C4 Therapeutics has 70 588 959 shares in issue
What is the market cap of C4 Therapeutics?
The market capitalisation of C4 Therapeutics is USD 273,18M
What is the 1 year trading range for C4 Therapeutics share price?
C4 Therapeutics has traded in the range of US$ 3,61 to US$ 11,88 during the past year
What is the PE ratio of C4 Therapeutics?
The price to earnings ratio of C4 Therapeutics is -2,06
What is the cash to sales ratio of C4 Therapeutics?
The cash to sales ratio of C4 Therapeutics is 13,16
What is the reporting currency for C4 Therapeutics?
C4 Therapeutics reports financial results in USD
What is the latest annual turnover for C4 Therapeutics?
The latest annual turnover of C4 Therapeutics is USD 20,76M
What is the latest annual profit for C4 Therapeutics?
The latest annual profit of C4 Therapeutics is USD -132,49M
What is the registered address of C4 Therapeutics?
The registered address for C4 Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the C4 Therapeutics website address?
The website address for C4 Therapeutics is www.c4therapeutics.com
Which industry sector does C4 Therapeutics operate in?
C4 Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MGIHMillennium Group International Holdings Ltd
US$ 4,58
(199,35%)
10,26M
ADDColor Star Technology Company Ltd
US$ 4,47
(106,94%)
4,05M
LICNLichen China Limited
US$ 0,2835
(34,94%)
15,39M
WAFUWah Fu Education Group Ltd
US$ 2,31
(32,76%)
4,44M
KWEKWESST Micro Systems Inc
US$ 0,7381
(32,56%)
3,41M
NEUPNeuphoria Therapeutics Inc
 3,79
(-42,84%)
35,89k
HOURHour Loop Inc
US$ 2,88
(-34,55%)
218,66k
BAOSBaosheng Media Group Holdings Ltd
US$ 5,16
(-27,32%)
67,9k
AVGRAvinger Inc
US$ 1,06
(-26,90%)
394,08k
CREVCarbon Revolution Public Ltd
US$ 6,72
(-26,64%)
32,7k
LICNLichen China Limited
US$ 0,2835
(34,94%)
15,39M
MGIHMillennium Group International Holdings Ltd
US$ 4,58
(199,35%)
10,26M
WAFUWah Fu Education Group Ltd
US$ 2,31
(32,76%)
4,44M
ADDColor Star Technology Company Ltd
US$ 4,47
(106,94%)
4,05M
LITMSnow Lake Resources Ltd
US$ 0,6911
(18,16%)
3,84M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
CCCC
C4 Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés